Back to Search
MARGARET SHIPP, MD
MD
Hematology & Oncology Physician
NPI: 1699851154Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
52610(MA)
Research & Publications (20)
Molecular signatures define new rational treatment targets in large B-cell lymphomas.
PMID 18024639·Hematology Am Soc Hematol Educ Program·2007
6-review
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
PMID 11786909·Nat Med·2002
3-trial
Awareness status and prevalence of hypertension in a group of urban Haitians: findings of a population-based survey.
PMID 11572408·Ethn Dis·2001
8-other
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.
PMID 19233845·J Biol Chem·2009
7-preclinical
Use of focus group data to develop recommendations for demographically segmented colorectal cancer educational strategies.
PMID 19395624·Health Educ Res·2009
8-other
Predictors of colorectal cancer knowledge and screening among church-attending African Americans and Whites in the Deep South.
PMID 18941876·J Community Health·2009
8-other
The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.
PMID 19036086·Br J Haematol·2009
8-other
AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
PMID 18519761·Clin Cancer Res·2008
8-other
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
PMID 18006696·Blood·2008
8-other
C677T methylene-H4-folate-reductase variant decreases binocular accommodation.
PMID 18317335·Optom Vis Sci·2008
8-other
Abnormal mammogram follow-up: do community lay health advocates make a difference?
PMID 18340089·Health Promot Pract·2008
2-rct
Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas.
PMID 17637749·Oncogene·2008
8-other
Glyco-array technology for efficient monitoring of plant cell wall glycosyltransferase activities.
PMID 17668317·Glycoconj J·2008
7-preclinical
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.
PMID 17670934·Proc Natl Acad Sci U S A·2007
8-other
Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic.
PMID 17365577·J Toxicol Environ Health A·2007
8-other
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
PMID 17389337·J Clin Oncol·2007
3-trial
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
PMID 17487729·Leuk Lymphoma·2007
3-trial
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
PMID 17545502·Blood·2007
8-other
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.
PMID 17692808·Cancer Cell·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY STREET, MAYER 513
BOSTON, MA 02115 - Phone
- (617) 632-3874
Quick Facts
- NPI
- 1699851154
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile